Company Tauriga Sciences, Inc. Other OTC
Equities
TAUG
US87669X2053
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
E-commerce
82.0
%
| 0 | 14.7 % | 0 | 82.0 % | +579.45% |
Wholesale
18.0
%
| 0 | 58.7 % | 0 | 18.0 % | -62.68% |
Sales per region
USD in Million | 2020 | Weight | 2021 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +21.73% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Seth M. Shaw
CEO | Chief Executive Officer | 45 | 12-08-21 |
Kevin P. Lacey
DFI | Director of Finance/CFO | 55 | 17-07-04 |
Keith A. Aqua
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-14 |
Adina Miles
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James V. Rosati
BRD | Director/Board Member | 74 | 21-03-07 |
Seth M. Shaw
CEO | Chief Executive Officer | 45 | 12-08-21 |
Director/Board Member | 46 | 21-03-07 | |
Director/Board Member | 75 | 15-08-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 299,908,214 | 299,908,214 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |